Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Biocept Inc BIOCQ

Healthcare Biotechnology
Biocept, Inc. is a molecular oncology diagnostics company. The Company focuses on developing and commercializing clinical diagnostic laboratory assays designed to identify rare tumor cells and cell-free tumor deoxyribonucleic acid (DNA) from blood and cerebrospinal fluid (CSF). Its product is branded and trademarked under the name CNSide. CNSide encompasses a suite of cellular and molecular... see more

Recent & Breaking News (GREY:BIOCQ)

BioClinica, Inc. Board of Directors Under Investigation for Potential Breaches of Fiduciary Duty by Glancy Binkow & Goldberg LLP

Business Wire January 30, 2013

The Law Firm of Levi & Korsinsky, LLP Announces Investigation into Possible Breaches of Fiduciary Duty by the Board of BioClinica, Inc. in Connection with the Sale of the Company to JLL Partners, Inc.

Business Wire January 30, 2013

BioClinica Shareholder Alert: Briscoe Law Firm and Powers Taylor, LLP Investigate Sale to JLL Partners

Business Wire January 30, 2013

Buyout Of BioClinica - Law Firm Challenges Fairness Of Price On Behalf Of Shareholders

PR Newswire January 30, 2013

JLL Partners to Acquire BioClinica and CoreLab Partners

Business Wire January 30, 2013

BioClinica, Inc. to Participate in Upcoming Industry Events and Demonstrate Global Technology-Enhanced Clinical Trial Management Capabilities

Business Wire January 10, 2013

BioClinica, Inc. to Present at the Sidoti Semi-Annual Micro-Cap Conference on January 7, 2013 in New York City

Business Wire December 20, 2012